Latest Financial Results
Q3 2024
Quarter Ended Sep 30, 2024
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2023
Report Links
Email Alerts
Receive updates straight into your inbox
Company Overview
HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The Company is creating the first ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions. This platform technology is designed to be used in portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health management. The Company holds 13 US and 4 international issued patents related to technology enablement.
View Management Team View Board of DirectorsInvestor Contact Information
Company
HeartBeam, Inc.
2118 Walsh Avenue
Suite 210
Santa Clara, CA 95050
T: 408-899-4443
Investor Relations
MZ North America
Chris Tyson
Executive Vice President
T: 949-491-8235
BEAT@mzgroup.us
Transfer Agent
VStock Transfer
18 Lafayette Place
Woodmere, NY 11598